1.Selected Conferences and Symposium (Invited Talks)
1)April 15, 2023 Yunnan University Statistics and Data Science Discipline Construction and Development Summit Forum, Kunming, Yunnan, China
2)April 8, 2023 Causal Inference in Real-World Research，China Innovative Drug (Device) Medicine Conference and CMAC Annual Meeting, Suzhou, Jiangsu, China
3)April 2, 2023 Application of Causal Inference in Regulatory Science of Drugs and Medical Devices, The Sixth China Drug Regulatory Science Conference, Beijing, China
4)4.March 30, 2023 Application of Causal Inference in Regulatory Science of Drugs and Medical Devices, The First Science and Technology Innovation Conference of Chongqing Taiji Industry（Group）, Chongqing, China
5)March 25, 2023 Statistical Methods for Evaluation of AI-based Medical Diagnostic System, The 3rd Workshop of Mathematical Oncology, Wenzhou, Zhejiang, China
6)
7)6.March 18, 2023 Causal Method of Traditional Chinese Medicine Clinical Efficiency Effect Evaluation，2023 WFCMS TCM Bigdata Industry Summit Forum, Chongqing, China
8)February 25, 2023 Application of Causal Inference in Clinical Research: Status Quo and Future Trend, The 4th China Medical Statistics Summit Forum, Shanghai, China
9)February 24, 2023 Design and Analysis for Clinical Study of AI-Based Medical Devices, Peking University, Beijing
10)February 16, 2023 The Intersection of Mathematics and Medicine: Biostatistics, Management Center of Shijingshan District Hospital, Beijing, China
11)November 30, 2022 Causal Inference with Truncation-by-Death and Unmeasured Confounding, Special Report on Statistics at School of Mathematics and Statistics, Northeastern University, online 
12)October 31, 2022 The Intersection of Mathematics and Medicine: Biostatistics, National Clinical Research Center for Child Health and Disorders & Child Hospital of Chongqing Medical University, online
13)October 27, 2022 The Intersection of Mathematics and Medicine, Peking University Caizhai Lecture, Beijing, China
14)September 18, 2022 Causal Inference of Truncation-by-Death with Unmeasured Confounding The 2022 Pacific Causal Inference Conference Academic Report, online
15)August 27, 2022 Causal Inference in the Presence of Unmeasured Confounders, China Biostatistics 2022 Annual Academic Conference, online
16)May 24,2022 A novel regression method for the analysis of MRMC-FROC Studies with application to evaluation of AI-based computer-aided diagnostic systems, Fudan University Zibin Forum, online
17)December 20, 2019.  Estimation of Optimal Individualized Treatment Rule Using the Covariate-Specific Treatment Effect Curve with High-dimensional Covariates. International Chinese Statistical Association International Conference, Zhejiang, China. 
18)Oct 3, 2019.  Statistical Methods for Finding Optimal Treatment Rule.  One-hour invited talk.  Fred Hutchinson Cancer Center, Seattle, WA.
19)September 20, 2019. Statistical Methods for Evaluation of AI-Based Medical Devices. Fifty-minutes invited talk. The 2019 Annual Symposium of China Society for Industrial and Applied Mathematics. Foshan, Guangdong, China. 
20)April 9, 2019.  Statistical Method for Selecting Optimal Treatment with High-dimensional Covariates. One-hour invited talk.  Chinese University of Hong Kong. Hong Kong, China. 
21)October 21, 2018. The mathematical basis of causal inference and its application in biostatistics. Fifty-minutes invited talk.  The 2018 Annual Symposium of The Chinese Mathematical Society (CMS). Guizhou, China.
22)July 26-29, 2016.  Big Data Analysis in Precision Medicine.. China Biostatistics Conference. Statistics and Big Data. Tianjin, China.
23)September 28-30, 2016. Selection the optimal treatment with conditional quantile treatment effect curve. 2016 ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop. Washington, DC. 
24)December 19, 2016. Dealing with Truncation by Death in Causal Inference from Observational Data. The 10th ICSA International Conference: Shanghai, China. 
25)March 4, 2016. Box-Cox Transformation Model for Skewed Mark Variable.  Department of Biostatistics, John Hopkins University, Baltimore, MD.
26)April 29, 2016. Predicting Life-time Medical Cost with Censored Data. Department of Biostatistics, Indiana University, Indianapolis, IN. 
27)August 3, 2016. Quantile-based Method for Choosing Optimal Treatments, Using Biomarkers.  JSM. Chicago, IL. 
28)Oct. 20, 2016. Statistical Methods for Analysis of Potentially Censored Skewed Data with an Application to Health Care Costs. School of Mathematical Science, Peking University, Beijing, China.
29)December 24, 2016. Using the Treatment Benefit Rate and Treatment Harm Rate to Assess the Heterogeneity of Treatment Effects. Center for Statistical Science,  Sichuan University.
30)August 10, 2015. Design and analyze a bridging study for companion diagnostic tests. Joint Statistical Meetings, Seattle, WA. 
31)July 12, 2015. Statistical Analysis of Clinical Trials for Personalized Treatments. Sixth Annual International Symposium on the Evaluation of Clinical Trials (Methodologies and Applications), Beijing, China.
32)August 5, 2014. Estimation of Accuracy of Diagnostic Tests Without a Gold Standard Using Latent Class Models. Joint Statistical Meetings, Boston, MA.
33)March 18, 2014. Estimation of covariate-specific areas under the ROC curve with partially missing gold standard. ENAR, Baltimore, USA. 
34)Oct 16-19, 2013. Design and Analysis of Postmarketing Studies. The International Conference on Postmarketing Surveillance of Chinese Medicines, Beijing, China.
35)August 6, 2013. Causal Mediation Analysis in Comparative Effectiveness Research. Joint Statistical Meetings 2013, Montreal, Canada.
36)July 6, 2013. Generalized Partially Linear Models for Incomplete Longitudinal Data In the Presence of Population-Level Information. Joint Conference of the Fifth Annual International Symposium on the Evaluation of Clinical Trials and the Fourth East Asia Regional Biometric Conference.
37)June 30-July 4, 2013. Causal inference with propensity score in the presence of missing outcome data. IMS-China International Conference on Statistics and Probability 2013, Chengdu, China.
38)June 6-8, 2013. Causal Inference in Broken Randomized Clinical Trials, Beyond Intention-To-Treat Analysis Advanced Workshop on Clinical Trials of Investigational New Drug. Beijing, China.
39)December 30, 2012. Statistical Inferences for the Analysis of Health Care Costs. Workshop on Modern Statistics. Shanghai University of Finance and Economics, Shanghai, China.
40)April 2. 2012. Semiparametric estimation of the covariate-specific ROC curve in presence of ignorable and non-ignorable verification bias. Eastern North American Region of the International Biometric Society (ENAR), Washington DC.
41)April 8, 2012. Designs and Sample Size Calculation for Postmarketing Studies. First International Workshop on Safety Surveillance of Post-market of Chinese Medicine, Beijing, China.
42)May 24, 2012. Optimal treatment Selection. 2012 Atlantic Causal Inference Conference. Baltimore, MD, USA.
43)June 26, 2012. Quantile Regression-Based Covariate-Specific ROC Curves. International Workshop on the Frontier of Statistics. Yunan, China.
44)June 23, 2012. Causal Inference in Randomized Clinical Trial. Advanced Seminar on Clinical Evaluation of New Drugs. Beijing, China.
45)July 7, 2012. Designs in Evaluation of Medical Devices. Second Joint Biostatistics Symposium. Beijing, China.
46)Juy 8, 2012 Latent-Variable Marginal Method for Multi-Level Incomplete Binary Data. Second Joint Biostatistics Symposium. Beijing, China.
47)July 31, 2012. Identifiability and Estimation of Causal Effects of a New Treatment on Patient’s Outcomes Truncated by Deaths. Joint Statistical Meetings (JSM). San Diego, CA.
48)Sept 27, 2012. Semiparametric estimation of the covariate-specific ROC curve. University of New York at Buffalo, Buffalo, NY.
49)Dec 30, 2012 Prediction of Skewed Health Care Costs. The Frontier of Modern Statistics Workshop. Shanghai, China.
50)August 2, 2011. Empirical Likelihood-Based Method Using Calibration for Longitudinal Data with Drop-Out. Joint Statistical Meetings. San Diego, CA, USA.
51)July 7, 2011. Assessing Predictive Biomarkers in Selecting a Best Treatment using BATE Curve. The 3rd IMS-China International Conference on Statistics and Probability, Xian, China.
52)July 4, 2011. Estimating the accuracy of diagnostic tests in the presence of verification bias. The Fourth Military Medical University, Xian, China.
53)July 2, 2011. Disease Progression Models with an Application to Alzheimer's Disease. The Fourth International Symposium on Clinical evaluation and application. Beijing, China.
54)June 8, 2011. Roles of Biostatistics in Advancement of Evidence-based and Personalized Medicine. Harbin Medical University, Harbin, China.
55)June 20, 2011. Semiparametric estimation of the covariate-specific ROC curve. Chinese Academy of Sciences. Beijing, China.
56)March 21, 2011. A Procedure for Evaluating Predictive Accuracy of Biomarkers for Selecting Optimal Treatment. Eastern North American Region of the International Biometric Society (ENAR), Miami, Florida, USA.
57)Aug. 16, 2010. Clinical and statistical evaluation of diagnostic agents in compliance with FDA guidelines). China Heart Congress & International Heart Forum, Beijing, China.
58)July 18, 2010. Biostatistics in Public Health and Medicine. Department of Mathematics and Physics, China University of Petroleum, Beijing, China.
59)July 7, 2010. Doubly Robust Estimation for Binary Longitudinal Data Analysis with Missing Response and Missing Covariates. An International Conference in Honor of P.L. Hsu’s 100th Birthday, Peking University, China.
60)July 10, 2010. Semi-parametric methods for correcting for verification bias under both ignorable and non-ignorable verification. The fourth International Forum on Statistics, Beijing, China.
61)July 18, 2010. Semi-parametric methods for correcting for verification bias under both ignorable and non-ignorable verification. First Joint Biostatistics Symposium. Beijing, China.
62)July 3, 2010. BATE Curve in Assessed of Clinical Utility of Predictive Biomarkers. Department of Biostatistics, the Second Military Medical University, Shanghai, China.
63)July 1, 2010. An Introduction to Survival Analysis in Medical Research. Department of Biostatistics, Chongqing Medical University.
64)March 23, 2010. A Procedure for Evaluating Predictive Accuracy of Biomarkers for Selecting Optimal Treatment. Eastern North American Region of the International Biometric Society (ENAR), New Orleans, USA.
65)August 3, 2009. Some New Models for Predicting Health Care Costs of Individual Patients. Joint Statistical Meetings. Washington, D.C., USA.
66)July 18, 2009. Analysis of correlated right-skewed semi-continuous data with a semi-parametric two-part mixed-effects transformation model. International Conference on Statistics and Management, Shanghai University of Finance and Economics, Shanghai, China.
67)June 27, 2009. Evaluation of Diagnostic tests in TCM, a keynote speaker at Third Annual International Symposium on the Evaluation of Clinical Trials Methodologies, Renmin University, Beijing, China.
68)April 29, 2009. Evaluating Markers for Treatment Selection Based on Survival Time. Statistical Issues in Developing Targeted Therapies. University of Pennsylvania Annual Conference on Statistical Issues in Clinical Trials: From Bench to Bedside to Community, Philadelphia, PA.